Health Care · Euronext Paris · FYE 06-30 · Prices AT CLOSE 2026-07-28 (EUR) — end-of-day, never a live or intraday quote
Last €10.75Day −0.46%Mkt cap $1.4B1Y +1.9%Off 52W high −6.9%Vol (1Y) 25.9%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 4,173 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
No fair-value, short-interest or ownership figures on file for GDS.PA.
| Sales (TTM)€5.24B |
| Earnings (TTM)-€54.1M |
| ROE−4.6% |
| Net margin−1.0% |
| Debt / equity1.66× |
| Total debt / EBITDA3.13× |
| Sales growth 3Y6.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+15.8% |
| 1Y+1.9% |
| 3Y−50.9% |
| 5Y−42.0% |
| 10Y−14.2% |
| Since incept. (ann.)+1.8% |
Total return through 2026-07-28 · series begins 2010-01-04. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)25.9% |
| Ann. volatility (3Y)30.3% |
| Sharpe (1Y)0.20 |
| Sharpe (3Y)−0.69 |
| Max drawdown (1Y)−16.6% |
| Max drawdown (3Y)−60.5% |
| Beta (3Y vs SPY)0.24 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for GDS.PA.
No reported quarters on file for GDS.PA.
